ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |